Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized controlled trial of comprehensive early intervention care in patients with first-episode psychosis in Japan: 1.5-year outcomes from the J-CAP study.
Nishida A, Ando S, Yamasaki S, Koike S, Ichihashi K, Miyakoshi Y, Maekawa S, Nakamura T, Natsubori T, Ichikawa E, Ishigami H, Sato K, Matsunaga A, Smith J, French P, Harima H, Kishi Y, Fujita I, Kasai K, Okazaki Y. Nishida A, et al. Among authors: kishi y. J Psychiatr Res. 2018 Jul;102:136-141. doi: 10.1016/j.jpsychires.2018.04.007. Epub 2018 Apr 8. J Psychiatr Res. 2018. PMID: 29653344 Clinical Trial.
Two-year effectiveness of risperidone and aripiprazole in the maintenance treatment of patients with recent-onset or chronic schizophrenia and related psychotic disorders: a retrospective multicenter study.
Yoshimura Y, Takeda T, Kishi Y, Harada T, Nomura A, Washida K, Yoshimura B, Sato K, Yada Y, Aoki S. Yoshimura Y, et al. Among authors: kishi y. Int Clin Psychopharmacol. 2018 May;33(3):147-154. doi: 10.1097/YIC.0000000000000209. Int Clin Psychopharmacol. 2018. PMID: 29406406
Associations between readmission and patient-reported measures in acute psychiatric inpatients: a study protocol for a multicenter prospective longitudinal study (the ePOP-J study).
Yamaguchi S, Ojio Y, Koike J, Matsunaga A, Ogawa M, Tachimori H, Kikuchi A, Kimura H, Inagaki A, Watanabe H, Kishi Y, Yoshida K, Hirooka T, Oishi S, Matsuda Y, Fujii C. Yamaguchi S, et al. Among authors: kishi y. Int J Ment Health Syst. 2019 Jun 7;13:40. doi: 10.1186/s13033-019-0298-3. eCollection 2019. Int J Ment Health Syst. 2019. PMID: 31182972 Free PMC article.
Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan.
Higuchi Y, Fujiwara M, Nakaya N, Fujimori M, Hayashibara C, So R, Shinkawa I, Sato K, Yada Y, Kodama M, Takenaka H, Kishi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Higuchi Y, et al. Among authors: kishi y. BMC Psychiatry. 2019 Nov 21;19(1):367. doi: 10.1186/s12888-019-2351-9. BMC Psychiatry. 2019. PMID: 31752799 Free PMC article. Clinical Trial.
Anti-NMDA-receptor antibody in initial diagnosis of mood disorder.
Kawai H, Takaki M, Sakamoto S, Shibata T, Tsuchida A, Yoshimura B, Yada Y, Matsumoto N, Sato K, Abe K, Okahisa Y, Kishi Y, Takao S, Tsutsui K, Kanbayashi T, Tanaka K, Yamada N. Kawai H, et al. Among authors: kishi y. Eur Neuropsychopharmacol. 2019 Sep;29(9):1041-1050. doi: 10.1016/j.euroneuro.2019.07.137. Epub 2019 Jul 26. Eur Neuropsychopharmacol. 2019. PMID: 31358437
981 results